Patent US4406830A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4406830A Expired / Lapsed US ⏱️ 0.0 years remaining

Regulatory glycoprotein for immune response and the use thereof in the production of T-cell growth factor

Assignee: SHANKSVILLE Corp NV A CORP OF NETHERLANDS ANTILLES
•
Filing: 1981-04-17
•
Granted: 1983-09-27
•
Expires: 2001-04-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A cell mediated immune response system glycoprotein having a molecular weight of about 90,000 and having at least one sialic acid moiety as a biologically active site is disclosed. The glycoprotein is specifically bound by wheat germ agglutinin and also by the hydrophobically binding ligant Blue A (Cibacron Blue F3G-A) but does not bind to lysine. The glycoprotein is a necessary cofactor with Interleukin-1 in the biosynthesis of T-cell growth factor (I1-2). A process for producing a serum-free and mitogen-free I1-2 in vitro by adding the glycoprotein to a serum-free- and mitogen-free Interleukin-1 preparation is described. The method for producing the serum-free and mitogen-free Interleukin-1 is also described. A chemically defined T-cell growth culture medium containing the new glycoprotein as the only protein substance is used in the above process and also provides a means for studying regulation of T-cell lymphocyte growth. Inhibitors for the formation of T-cell blasts in cell mediated immunological response provide a powerful new tool for preventing host-graft rejection. These inhibitors are alkylating agents for serine esterase enzymes which have been found to be involved in the cell mediated immunological response system which generates natural Killer (NK) cells, the latter being responsible for graft rejection in a host.

Inventors

  • 👤 Hans-Ake Fabricius
  • 👤 Eckart U. Kottgen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 14:27
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/54; C07K14/55; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 87 words
A biologically active blood serum glycoprotein having a molecular weight of about 90,000 and being able to cause T-cell growth factor production in the presence of Interleukin-1 and T-lymphocytes; said glycoprotein being further characterized by at least one sialic acid moiety as a biologically active site; by retaining more than one-half of its biological activity after being heated to 80° C. for 30 minutes; by its specific binding affinity to wheat germ agglutinin and Cibacron Blue A; and by its lack of specific binding affinity to lysine.
Claim 2
Dependent Claim 87 words
A biologically active blood serum glycoprotein having a molecular weight of about 90,000 and being able to cause T-cell growth factor production in the presence of Interleukin-1 and T-lymphocytes; said glycoprotein being further characterized by at least one sialic acid moiety as a biologically active site; by retaining more than one-half of its biological activity after being heated to 80° C. for 30 minutes; by its specific binding affinity to wheat germ agglutinin and Cibacron Blue A; and by its lack of specific binding affinity to lysine.
Claim 3
Dependent Claim 52 words
In a chemically defined liquid cell culture medium containing water, cell growth nutrients and protein, the improvement wherein said proten consists essentially of the blood serum glycoprotein as defined in claim 1, said culture medium permitting the formation of T-cell growth factor in the presence of peripheral mononuclear blood cells and Interleukin-1.

References Cited (Backward Citations)

US4146603A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-09-26 1987-03-28 1987-09-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-09-26 1991-03-28 1991-09-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-09-26 1995-03-28 1995-09-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag